Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.80 |
| ▸ | F10 | P00742 | 3/20 | 0.72 |
| ▸ | PLG | P00747 | 3/20 | 0.72 |
| ▸ | PLAU | P00749 | 3/20 | 0.72 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.72 |
| ▸ | ASIC3 | Q9UHC3 | 4/20 | 0.71 |
| ▸ | HPN | P05981 | 7/20 | 0.65 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.63 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.63 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.63 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.63 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.63 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.63 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.63 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.63 |
| ▸ | PRMT7 | Q9NVM4 | 1/20 | 0.63 |
| ▸ | PLAT | P00750 | 1/20 | 0.61 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.61 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.61 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7876123 | 0.98 | F2 (0.82) | F2F10PLGPLAUPRSS1 | |
| SCHEMBL13208176 | 0.89 | F2 (1.00) | F2F10PLGPLAUPRSS1 | |
| SCHEMBL29428907 | 0.87 | PRMT5 (0.81) | F2F10PLGPLAUPRSS1 | |
| Dapi SCHEMBL235865 | 0.85 | PRMT5 (0.83) | F2F10PLGPLAUPRSS1 | |
| Dapi SCHEMBL28176609 | 0.85 | PRMT5 (0.83) | F2F10PLGPLAUPRSS1 | |
| Dapi SCHEMBL29350295 | 0.85 | PRMT5 (0.83) | F2F10PLGPLAUPRSS1 | |
| SCHEMBL29493199 | 0.84 | F2 (0.70) | F2F10PLGPLAUPRSS1 | |
| Dapi SCHEMBL2464378 | 0.84 | PRMT5 (0.81) | F2F10PLGPLAUPRSS1 | |
| Dapi SCHEMBL94350 | 0.84 | PRMT5 (0.81) | F2F10PLGPLAUPRSS1 | |
| Dapi SCHEMBL30442885 | 0.84 | PRMT5 (0.81) | F2F10PLGPLAUPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220096441-A1 | TREATMENT OF ACANTHAMOEBA OR BALAMUTHIA TROPHOZOITES AND/OR CYSTS | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2022-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220096441-A1 | TREATMENT OF ACANTHAMOEBA OR BALAMUTHIA TROPHOZOITES AND/OR CYSTS | PKD2, PKD1, MUC1 | F2 1185/4885F10 1579/4885PLG 141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.